266
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Identification of lncRNA-Associated ceRNA Network in High-Grade Serous Ovarian Cancer Metastasis

, , , , , , & show all
Pages 1175-1191 | Received 09 Mar 2020, Accepted 11 May 2020, Published online: 28 May 2020

References

  • Siegel RL , MillerKD , JemalA. Cancer Statistics, 2017. CA Cancer J. Clin.67(1), 7–30 (2017).
  • Siegel RL , MillerKD , JemalA. Cancer statistics, 2019. CA Cancer J. Clin.69(1), 7–34 (2019).
  • Webb PM , JordanSJ. Epidemiology of epithelial ovarian cancer. Best Pract. Res. Clin. Obstet. Gynaecol.41, 3–14 (2017).
  • Pradeep S , KimSW , WuSYet al. Hematogenous metastasis of ovarian cancer: rethinking mode of spread. Cancer Cell26(1), 77–91 (2014).
  • Yeung T-L , LeungCS , YipK-P , AuYeung CL , WongSTC , MokSC. Cellular and molecular processes in ovarian cancer metastasis. A review in the theme: cell and molecular processes in cancer metastasis. Am. J. Physiol. Cell Physiol.309(7), C444–C456 (2015).
  • Lin C , YangL. Long noncoding RNA in cancer: wiring signaling circuitry. Trends Cell Biol.28(4), 287–301 (2018).
  • Batista PJ , ChangHY. Long noncoding RNAs: cellular address codes in development and disease. Cell152(6), 1298–1307 (2013).
  • Rupaimoole R , SlackFJ. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat. Rev. Drug Discov.16(3), 203–222 (2017).
  • Salmena L , PolisenoL , TayY , KatsL , PandolfiPP. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?Cell146(3), 353–358 (2011).
  • Gokulnath P , DeCristofaro T , ManipurIet al. Long non-coding RNA MAGI2-AS3 is a new player with a tumor suppressive role in high-grade serous ovarian carcinoma. Cancers (Basel)11(12), (2019).
  • Kolde R . pheatmap: Pretty Heatmaps (2015). https://CRAN.R-project.org/package=pheatmap
  • Mou HZ , XuSH , ZhangYY. [The establishment of human ovarian carcinoma cell line HO-8910 and its characteristics]. Zhonghua Fu Chan Ke Za Zhi29(3), 162–164 (1994).
  • Zheng Y , XuQ , LiuMet al. lnCAR: a comprehensive resource for lncRNAs from cancer arrays. Cancer Res.79(8), 2076–2083 (2019).
  • Cao Z , PanX , YangY , HuangY , ShenH-B. The lncLocator: a subcellular localization predictor for long non-coding RNAs based on a stacked ensemble classifier. Bioinformatics34(13), 2185–2194 (2018).
  • Betel D , KoppalA , AgiusP , SanderC , LeslieC. Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites. Genome Biol.11(8), R90 (2010).
  • Rehmsmeier M , SteffenP , HochsmannM , GiegerichR. Fast and effective prediction of microRNA/target duplexes. RNA10(10), 1507–1517 (2004).
  • Kertesz M , IovinoN , UnnerstallU , GaulU , SegalE. The role of site accessibility in microRNA target recognition. Nat. Genet.39(10), 1278–1284 (2007).
  • Barrett T , WilhiteSE , LedouxPet al. NCBI GEO: archive for functional genomics data sets–update. Nucleic Acids Res.41(Database issue), D991–D995 (2013).
  • Sallinen H , JanhonenS , PölönenPet al. Comparative transcriptome analysis of matched primary and distant metastatic ovarian carcinoma. BMC Cancer19(1), 1121 (2019).
  • Huang DW , ShermanBT , LempickiRA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc.4(1), 44–57 (2009).
  • Ginestet C . ggplot2: elegant graphics for data analysis. J. R.Stat. Soc.174(1), 245–246 (2009).
  • Tang Z , LiC , KangB , GaoG , LiC , ZhangZ. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res.45(W1), W98–W102 (2017).
  • Győrffy B , SurowiakP , BudcziesJ , LánczkyA. Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer. PLoS ONE8(12), e82241 (2013).
  • Tang Z , ZhangN , DiW , LiW. Inhibition of microtubule-associated protein 1 light chain 3B via small-interfering RNA or 3-methyladenine impairs hypoxia-induced HO8910PM and HO8910 epithelial ovarian cancer cell migration and invasion and is associated with RhoA and alterations of the actin cytoskeleton. Oncol. Rep.33(3), 1411–1417 (2015).
  • Vlachos IS , ZagganasK , ParaskevopoulouMDet al. DIANA-miRPath v3.0: deciphering microRNA function with experimental support. Nucleic Acids Res.43(W1), W460–W466 (2015).
  • Yang G , LuW , YuDet al. Quantitative analysis of differential proteome expression in epithelial-to-mesenchymal transition of bladder epithelial cells using SILAC method. Molecules21(1), 84 (2016).
  • Zou X , BlankM. Targeting p38 MAP kinase signaling in cancer through post-translational modifications. Cancer Lett.384, 19–26 (2017).
  • Wu Y , YuanM , SuWet al. The constitutively active PKG II mutant effectively inhibits gastric cancer development a blockade of EGF/EGFR-associated signalling cascades. Ther. Adv. Med. Oncol.10, 1758834017751635 (2018).
  • Zhang Y , FanY , HuangSet al. Thymoquinone inhibits the metastasis of renal cell cancer cells by inducing autophagy via AMPK/mTOR signaling pathway. Cancer Sci.109(12), 3865–3873 (2018).
  • Landen CN , BirrerMJ , SoodAK. Early events in the pathogenesis of epithelial ovarian cancer. J. Clin. Oncol.26(6), 995–1005 (2008).
  • Jemal A , BrayF , CenterMM , FerlayJ , WardE , FormanD. Global cancer statistics. CA Cancer J. Clin.61(2), 69–90 (2011).
  • Cao Y , ShiH , RenF , JiaY , ZhangR. Long non-coding RNA CCAT1 promotes metastasis and poor prognosis in epithelial ovarian cancer. Exp. Cell Res.359(1), 185–194 (2017).
  • Qiu JJ , LinYY , YeLCet al. Overexpression of long non-coding RNA HOTAIR predicts poor patient prognosis and promotes tumor metastasis in epithelial ovarian cancer. Gynecol. Oncol.134(1), 121–128 (2014).
  • Xu X , PanL , ZhuoMet al. Increased expression of LncRNA BANCR and its prognostic significance in human epithelial ovarian cancer. Eur. J. Gynaecol. Oncol.38(3), 449–452 (2017).
  • Chen Y , BiF , AnY , YangQ. Identification of pathological grade and prognosis-associated lncRNA for ovarian cancer. J. Cell. Biochem.120(9), 14444–14454 (2019).
  • Xu L , WuY , CheXet al. Cox-LASSO analysis reveals a ten-lncRNA signature to predict outcomes in patients with high-grade serous ovarian cancer. DNA Cell Biol.38(12), 1519–1528 (2019).
  • Zhu L , GuoQ , LuXet al. CTD-2020K17.1, a novel long non-coding RNA, promotes migration, invasion, and proliferation of serous ovarian cancer Cells In Vitro. Med. Sci. Monit.24, 1329–1339 (2018).
  • Yang Y , ZhangH , XieYet al. Preliminary screening and identification of differentially expressed metastasis-related ncRNAs in ovarian cancer. Oncol. Lett.15(1), 368–374 (2018).
  • Zhang S , ZhangX , SunQet al. LncRNA NR2F2-AS1 promotes tumourigenesis through modulating BMI1 expression by targeting miR-320b in non-small cell lung cancer. J. Cell. Mol. Med.23(3), 2001–2011 (2019).
  • Liu J , QianJ , MoQ , TangL , XuQ. LncRNA NR2F2-AS1 silencing induces cell cycle arrest in G0/G1 phase via downregulating Cyclin D1 in colorectal cancer. Cancer Manag. Res.12, 1835–1843 (2020).
  • Fu X , WangD , ShuT , CuiD , FuQ. LncRNA NR2F2-AS1 positively regulates CDK4 to promote cancer cell proliferation in prostate carcinoma. Aging Male doi:10.1080/13685538.2019.16701571-7(2019) ( Epub ahead of print).
  • Cho MS , NohK , HaemmerleMet al. Role of ADP receptors on platelets in the growth of ovarian cancer. Blood130(10), 1235–1242 (2017).
  • Cai P , OttenABC , ChengBet al. A genome-wide long noncoding RNA CRISPRi screen identifies as a novel regulator of epidermal homeostasis. Genome Res.30(1), 22–34 (2020).
  • Xu D , SongM , ChaiCet al. Exosome-encapsulated miR-6089 regulates inflammatory response via targeting TLR4. J. Cell. Physiol.234(2), 1502–1511 (2019).
  • Yan S , WangP , WangJet al. Long non-coding RNA HIX003209 promotes inflammation by sponging miR-6089 via TLR4/NF-κB signaling pathway in rheumatoid arthritis. Front. Immunol.10, 2218 (2019).
  • Gaudet P , LivstoneMS , LewisSE , ThomasPD. Phylogenetic-based propagation of functional annotations within the gene ontology consortium. Brief. Bioinform.12(5), 449–462 (2011).
  • Yu Y , FujiiS , YuanJet al. Epigenetic regulation of ARHI in breast and ovarian cancer cells. Ann. NY Acad. Sci.983, 268–277 (2003).
  • Sutton MN , YangH , HuangGYet al. RAS-related GTPases DIRAS1 and DIRAS2 induce autophagic cancer cell death and are required for autophagy in murine ovarian cancer cells. Autophagy14(4), 637–653 (2018).
  • Mao W , PetersHL , SuttonMNet al. The role of vascular endothelial growth factor, interleukin 8, and insulinlike growth factor in sustaining autophagic DIRAS3-induced dormant ovarian cancer xenografts. Cancer125(8), 1267–1280 (2019).
  • Li L , GaoP , LiYet al. JMJD2A-dependent silencing of Sp1 in advanced breast cancer promotes metastasis by downregulation of DIRAS3. Breast Cancer Res. Treat.147(3), 487–500 (2014).
  • Niemczyk M , ItoY , HuddlestonJet al. Imprinted chromatin around DIRAS3 regulates alternative splicing of GNG12-AS1, a long noncoding RNA. Am. J. Hum. Genet.93(2), 224–235 (2013).
  • Zhang S , LuZ , UnruhAKet al. Clinically relevant microRNAs in ovarian cancer. Mol. Cancer Res.13(3), 393–401 (2015).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.